Copyright Reports & Markets. All rights reserved.

Global Methylphenidate Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Methylphenidate Drug

      • 1.1 Definition of Methylphenidate Drug
      • 1.2 Methylphenidate Drug Segment by Type
        • 1.2.1 Global Methylphenidate Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Tablet
        • 1.2.3 Capsule
      • 1.3 Methylphenidate Drug Segment by Applications
        • 1.3.1 Global Methylphenidate Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Children(6-17 years)
        • 1.3.3 Adult
      • 1.4 Global Methylphenidate Drug Overall Market
        • 1.4.1 Global Methylphenidate Drug Revenue (2014-2025)
        • 1.4.2 Global Methylphenidate Drug Production (2014-2025)
        • 1.4.3 North America Methylphenidate Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Methylphenidate Drug Status and Prospect (2014-2025)
        • 1.4.5 China Methylphenidate Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Methylphenidate Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Methylphenidate Drug Status and Prospect (2014-2025)
        • 1.4.8 India Methylphenidate Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Methylphenidate Drug
      • 2.3 Manufacturing Process Analysis of Methylphenidate Drug
      • 2.4 Industry Chain Structure of Methylphenidate Drug

      3 Development and Manufacturing Plants Analysis of Methylphenidate Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Methylphenidate Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Methylphenidate Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Methylphenidate Drug Production and Capacity Analysis
      • 4.2 Methylphenidate Drug Revenue Analysis
      • 4.3 Methylphenidate Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Methylphenidate Drug Regional Market Analysis

      • 5.1 Methylphenidate Drug Production by Regions
        • 5.1.1 Global Methylphenidate Drug Production by Regions
        • 5.1.2 Global Methylphenidate Drug Revenue by Regions
      • 5.2 Methylphenidate Drug Consumption by Regions
      • 5.3 North America Methylphenidate Drug Market Analysis
        • 5.3.1 North America Methylphenidate Drug Production
        • 5.3.2 North America Methylphenidate Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Methylphenidate Drug Import and Export
      • 5.4 Europe Methylphenidate Drug Market Analysis
        • 5.4.1 Europe Methylphenidate Drug Production
        • 5.4.2 Europe Methylphenidate Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Methylphenidate Drug Import and Export
      • 5.5 China Methylphenidate Drug Market Analysis
        • 5.5.1 China Methylphenidate Drug Production
        • 5.5.2 China Methylphenidate Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Methylphenidate Drug Import and Export
      • 5.6 Japan Methylphenidate Drug Market Analysis
        • 5.6.1 Japan Methylphenidate Drug Production
        • 5.6.2 Japan Methylphenidate Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Methylphenidate Drug Import and Export
      • 5.7 Southeast Asia Methylphenidate Drug Market Analysis
        • 5.7.1 Southeast Asia Methylphenidate Drug Production
        • 5.7.2 Southeast Asia Methylphenidate Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Methylphenidate Drug Import and Export
      • 5.8 India Methylphenidate Drug Market Analysis
        • 5.8.1 India Methylphenidate Drug Production
        • 5.8.2 India Methylphenidate Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Methylphenidate Drug Import and Export

      6 Methylphenidate Drug Segment Market Analysis (by Type)

      • 6.1 Global Methylphenidate Drug Production by Type
      • 6.2 Global Methylphenidate Drug Revenue by Type
      • 6.3 Methylphenidate Drug Price by Type

      7 Methylphenidate Drug Segment Market Analysis (by Application)

      • 7.1 Global Methylphenidate Drug Consumption by Application
      • 7.2 Global Methylphenidate Drug Consumption Market Share by Application (2014-2019)

      8 Methylphenidate Drug Major Manufacturers Analysis

      • 8.1 Janssen Pharmaceuticals
        • 8.1.1 Janssen Pharmaceuticals Methylphenidate Drug Production Sites and Area Served
        • 8.1.2 Janssen Pharmaceuticals Product Introduction, Application and Specification
        • 8.1.3 Janssen Pharmaceuticals Methylphenidate Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 NEOS Therapeutics
        • 8.2.1 NEOS Therapeutics Methylphenidate Drug Production Sites and Area Served
        • 8.2.2 NEOS Therapeutics Product Introduction, Application and Specification
        • 8.2.3 NEOS Therapeutics Methylphenidate Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Rhodes Pharmaceuticals
        • 8.3.1 Rhodes Pharmaceuticals Methylphenidate Drug Production Sites and Area Served
        • 8.3.2 Rhodes Pharmaceuticals Product Introduction, Application and Specification
        • 8.3.3 Rhodes Pharmaceuticals Methylphenidate Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Noven Therapeutics
        • 8.4.1 Noven Therapeutics Methylphenidate Drug Production Sites and Area Served
        • 8.4.2 Noven Therapeutics Product Introduction, Application and Specification
        • 8.4.3 Noven Therapeutics Methylphenidate Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Ironshore Pharmaceuticals
        • 8.5.1 Ironshore Pharmaceuticals Methylphenidate Drug Production Sites and Area Served
        • 8.5.2 Ironshore Pharmaceuticals Product Introduction, Application and Specification
        • 8.5.3 Ironshore Pharmaceuticals Methylphenidate Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Lannett Company
        • 8.6.1 Lannett Company Methylphenidate Drug Production Sites and Area Served
        • 8.6.2 Lannett Company Product Introduction, Application and Specification
        • 8.6.3 Lannett Company Methylphenidate Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Novartis
        • 8.7.1 Novartis Methylphenidate Drug Production Sites and Area Served
        • 8.7.2 Novartis Product Introduction, Application and Specification
        • 8.7.3 Novartis Methylphenidate Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Teva
        • 8.8.1 Teva Methylphenidate Drug Production Sites and Area Served
        • 8.8.2 Teva Product Introduction, Application and Specification
        • 8.8.3 Teva Methylphenidate Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Tris Pharma
        • 8.9.1 Tris Pharma Methylphenidate Drug Production Sites and Area Served
        • 8.9.2 Tris Pharma Product Introduction, Application and Specification
        • 8.9.3 Tris Pharma Methylphenidate Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Amneal
        • 8.10.1 Amneal Methylphenidate Drug Production Sites and Area Served
        • 8.10.2 Amneal Product Introduction, Application and Specification
        • 8.10.3 Amneal Methylphenidate Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Impax Laboratories
      • 8.12 Mylan
      • 8.13 Trigen Laboratories
      • 8.14 Sun Pharmaceutical
      • 8.15 Oxford Pharm
      • 8.16 Novel Laboratories
      • 8.17 Breckenridge Pharmaceutical

      9 Development Trend of Analysis of Methylphenidate Drug Market

      • 9.1 Global Methylphenidate Drug Market Trend Analysis
        • 9.1.1 Global Methylphenidate Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Methylphenidate Drug Regional Market Trend
        • 9.2.1 North America Methylphenidate Drug Forecast 2019-2025
        • 9.2.2 Europe Methylphenidate Drug Forecast 2019-2025
        • 9.2.3 China Methylphenidate Drug Forecast 2019-2025
        • 9.2.4 Japan Methylphenidate Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Methylphenidate Drug Forecast 2019-2025
        • 9.2.6 India Methylphenidate Drug Forecast 2019-2025
      • 9.3 Methylphenidate Drug Market Trend (Product Type)
      • 9.4 Methylphenidate Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Methylphenidate Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Methylphenidate Drug is a central nervous system stimulant prescription medicine. It is used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

        The global Methylphenidate Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Methylphenidate Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Methylphenidate Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Methylphenidate Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Methylphenidate Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Janssen Pharmaceuticals
        NEOS Therapeutics
        Rhodes Pharmaceuticals
        Noven Therapeutics
        Ironshore Pharmaceuticals
        Lannett Company
        Novartis
        Teva
        Tris Pharma
        Amneal
        Impax Laboratories
        Mylan
        Trigen Laboratories
        Sun Pharmaceutical
        Oxford Pharm
        Novel Laboratories
        Breckenridge Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Tablet
        Capsule

        Segment by Application
        Children(6-17 years)
        Adult

        Buy now